Tumor-resident regulatory T cells in pancreatic cancer express the αvβ5 integrin as a targetable activation marker
K. Suzuki, Y. Kunisada, N. Miyamura, S. Eikawa, T. Hurtado de Mendoza, E. S. Mose, C. Lu, Y. Kuroda, E. Ruoslahti, A. M. Lowy, K. N. Sugahara
This study identifies αvβ5 integrin as a marker for activated tumor-resident Tregs in PDAC, showing that targeting it enhances immune checkpoint therapy.
bioRxiv · May 24, 2023 · PreprintCancer Biology